Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jun 5, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Xeris Biopharma Holdings, Inc.
| 50K |
—
|
—
| +43.80% | 164.14K |
Jun 5
| |||||||
Xeris Biopharma Holdings, Inc.
| 6.47K |
—
|
—
| +6.01% | 114.14K |
Mar 15
| |||||||
Laboratory Corp of America Holdings
| 947 |
—
|
—
| +8.65% | 11.9K |
Feb 6 - Feb 7
| |||||||
American Oncology Network, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Xeris Biopharma Holdings, Inc.
| 42.5K |
—
|
—
| +65.21% | 107.67K |
Jun 7
| |||||||
Venus Concept Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 24
| |||||||
Laboratory Corp of America Holdings
| 742 |
—
|
—
| +7.27% | 10.95K |
Feb 11
| |||||||
Laboratory Corp of America Holdings
|
0
|
—
|
—
|
—
|
0
|
Feb 7
| |||||||
Alimera Sciences Inc
|
0
|
—
|
—
|
—
|
0
|
Jan 4
| |||||||
Venus Concept Inc.
|
0
|
—
|
—
|
—
|
0
|
Nov 18
| |||||||
Xeris Biopharma Holdings, Inc.
| 15K |
—
|
—
| +29.90% | 65.17K |
Jun 8
| |||||||
Venus Concept Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 25
| |||||||
Laboratory Corp of America Holdings
|
0
|
—
|
—
|
—
|
0
|
Feb 11
| |||||||
Laboratory Corp of America Holdings
| 771 |
—
|
—
| +8.17% | 10.21K |
Feb 2
| |||||||
Venus Concept Inc.
| 1.6M |
$1.25 | $2,000,000.00 | +30.80% | 6.8M |
Dec 15
| |||||||
Alimera Sciences Inc
|
0
|
—
|
—
|
—
|
0
|
Nov 2
| |||||||
Xeris Biopharma Holdings, Inc.
| 50.17K |
—
|
—
|
∞
| 50.17K |
Oct 5
| |||||||
Strongbridge Biopharma Plc
| -63.99K |
—
|
—
| -100.00% |
0
|
Oct 5
| |||||||
Xeris Biopharma Holdings, Inc.
| 50.17K |
—
|
—
|
∞
| 50.17K |
Oct 5
| |||||||
Strongbridge Biopharma Plc
| -17.76K |
$2.06 | -$36,591.78 | -21.73% | 63.99K |
Oct 1
| |||||||
Xeris Biopharma Holdings, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Strongbridge Biopharma Plc
| 40K |
—
|
—
| +95.79% | 81.76K |
May 18
| |||||||
Strongbridge Biopharma Plc
| -19.20K |
$2.35 | -$45,120.00 | -31.50% | 41.76K |
May 14
| |||||||
Venus Concept Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 26
| |||||||
Laboratory Corp of America Holdings
| 986 |
—
|
—
| +11.67% | 9.44K |
Feb 4
| |||||||
Laboratory Corp of America Holdings
|
0
|
—
|
—
|
—
|
0
|
Feb 2
| |||||||
Alimera Sciences Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 18
| |||||||
Venus Concept Inc.
| 1.2M |
—
|
—
| +30.03% | 5.2M |
Jun 16
| |||||||
Castle Biosciences Inc
| -250.00K |
$34.50 | -$8,624,590.00 | -14.85% | 1.43M |
May 12
|
Scheduled
| ||||||
Strongbridge Biopharma Plc
| -19.04K |
$2.86 | -$54,465.84 | -23.81% | 60.96K |
May 15
| |||||||
Strongbridge Biopharma Plc
| 40K |
—
|
—
| +100.00% | 80K |
May 14
| |||||||
Castle Biosciences Inc
| -250.00K |
$34.50 | -$8,624,600.00 | -14.85% | 1.43M |
May 12
|
Scheduled
| ||||||
Venus Concept Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 30
| |||||||
Venus Concept Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 18
| |||||||
Castle Biosciences Inc
| -25.00K |
$32.03 | -$800,750.00 | -1.46% | 1.68M |
Feb 19
|
Scheduled
| ||||||
Castle Biosciences Inc
| -25.00K |
$32.01 | -$800,250.00 | -1.44% | 1.71M |
Feb 13
|
Scheduled
| ||||||
Laboratory Corp of America Holdings
| 1.23K |
—
|
—
| +16.98% | 8.45K |
Feb 12
| |||||||
Castle Biosciences Inc
| -25.00K |
$31.03 | -$775,750.00 | -1.42% | 1.73M |
Feb 6
|
Scheduled
| ||||||
Laboratory Corp of America Holdings
|
0
|
—
|
—
|
—
|
0
|
Feb 4
| |||||||
Castle Biosciences Inc
| -50.00K |
$30.54 | -$1,526,912.50 | -2.76% | 1.76M |
Jan 31 - Feb 3
|
Scheduled
| ||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.